• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 13- Current Developments of Pharmacotherapeutic Spending

Video

During this segment, David Calabrese, RPh, MHP, explores the current trends of pharmacotherapeutic spending for the treatment of chronic conditions.

Mr Calabrese explains that from a research and developmental stage, there has been a stronger trend toward investing within the specialty market, rather than on traditional products.

Over 30 new products have been approved in the United States over the past year, and this number is expected to continue to grow annually. For this reason, investors seem more interested in supporting today’s higher-cost, complex therapies rather than traditional products for the treatment of chronic conditions.

Related Videos
JoAnn Pinkerton, MD
Susan Cantrell, CEO of AMCP
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Dr Brian Mulherin
Kelley L. Julian, PharmD, BCOP
Dr Vivek Subbiah
Robert Andrews, former US representative for New Jersey and CEO of the Health Transformation Alliance
Robert Andrews, chief executive officer, Health Transformation Alliance
Notebook created AI Image
Related Content
Advancing Myasthenia Gravis Treatment Access and Management

Advancing Myasthenia Gravis Treatment Access and Management

October 31st 2025
Article

Experts discuss personalized myasthenia gravis treatment, emphasizing patient education and engagement for optimal care and advocacy in managing this variable disease.

Read More

Managed Care Cast Square thumbnail

Advocacy, Access, and Awareness: Addressing Barriers in Hearing Health

October 28th 2025
Podcast

Discover how the Hearing Loss Association of America advocates for hearing loss awareness and hearing health integration through a dialogue with Barbara Kelley, executive director.

Listen

Lawmaking | Image Credit: Polonio Video - stock.adobe.com

New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access

October 30th 2025
Article

PBM legislation is rising nationwide, which experts emphasize could increase costs and hinder patient care.

Read More

Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN

Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN

October 21st 2025
Podcast

Melanie T. Turk, PhD, RN, discusses her study on nationwide challenges program suppliers face in implementing the Medicare Diabetes Prevention Program (MDPP).

Listen

Geni Tunstall, JD, associate vice president of regulatory affairs, Academy of Managed Care Pharmacy

Key Federal Legislation Impacting Managed Care Pharmacy: Geni Tunstall, JD

October 29th 2025
Article

Geni Tunstall, JD, discusses how pharmacy benefit manager reforms, Medicaid changes, and the MAHA initiative may impact managed care pharmacy operations.

Read More

Marky Markary, MD, Robert F. Kennedy, Jr, and Mehmet Oz, MD

FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development

October 29th 2025
Article

The FDA announced draft guidance to remove clinical efficacy studies for biosimilars and also issued the position that all biosimilars in the US should be interchangeable.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.